Jin Zhicheng, Huang Rongrong, Christensen Paul, Bertholf Roger L, Yi Xin
Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX 77030, USA.
Department of Pathology and Immunology, Baylor College of Medicine, Harris Health System Ben Taub Hospital, Houston, TX 77030, USA.
J Clin Med. 2023 Sep 19;12(18):6054. doi: 10.3390/jcm12186054.
An accurate measurement of the glomerular filtration rate (GFR) is essential for detecting renal insufficiency in living kidney donors. Iohexol is a "near-ideal" exogenous filtration marker for GFR measurements that has attracted increasing interest in clinical practice because it is non-toxic, non-radioactive, readily available, and easy to measure. In this study, we aimed to set up a laboratory test to conveniently assess the plasma clearance of iohexol in living kidney donors.
A workflow was established in the institution's infusion clinic to administer iohexol and to collect three timed blood samples from renal transplant donors. Iohexol was thereafter measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The serum proteins were precipitated and the supernatant containing iohexol was diluted prior to the LC-MS/MS analysis. The LC-MS/MS method was developed on a Thermo Vanquish UHPLC coupled with a TSQ Endura triple quadruple mass spectrometer with a total run time of 2.5 min. The analytical performance of the method was assessed.
The LC-MS/MS method demonstrated a good analytical performance. To calculate the iohexol clearance rate and the GFR, automated data integration and a result calculation were accomplished by using a custom Python script. Automated result reporting was achieved using a laboratory informatics system (LIS) vendor's direct media interface.
We developed and implemented a laboratory test to assess the plasma clearance of iohexol. A workflow was established in the hospital to reliably measure the GFR in living kidney donors, with a potential to be further expanded into other areas where an accurate GFR measurement is needed.
准确测量肾小球滤过率(GFR)对于检测活体肾供体的肾功能不全至关重要。碘海醇是一种用于GFR测量的“近乎理想”的外源性滤过标志物,因其无毒、无放射性、易于获取且易于测量,在临床实践中引起了越来越多的关注。在本研究中,我们旨在建立一种实验室检测方法,以方便地评估活体肾供体中碘海醇的血浆清除率。
在该机构的输液门诊建立了一个工作流程,用于给予碘海醇并从肾移植供体中采集三份定时血样。此后,通过液相色谱-串联质谱法(LC-MS/MS)测量碘海醇。在进行LC-MS/MS分析之前,沉淀血清蛋白并稀释含有碘海醇的上清液。LC-MS/MS方法是在Thermo Vanquish超高效液相色谱仪与TSQ Endura三重四极杆质谱仪联用的基础上开发的,总运行时间为2.5分钟。评估了该方法的分析性能。
LC-MS/MS方法显示出良好的分析性能。为了计算碘海醇清除率和GFR,使用自定义Python脚本完成了自动数据整合和结果计算。使用实验室信息系统(LIS)供应商的直接介质接口实现了自动结果报告。
我们开发并实施了一种实验室检测方法来评估碘海醇的血浆清除率。在医院建立了一个工作流程,以可靠地测量活体肾供体的GFR,并有可能进一步扩展到其他需要准确测量GFR的领域。